Inlyta is a brand-name medication that contains the active ingredient axitinib and is used for the treatment of advanced kidney cancer. This medication belongs to a group of drugs known as tyrosine kinase inhibitors (TKIs). It works by blocking the action of the tyrosine kinase protein in cancer cells, which prevents the cancer cells from growing and dividing. Here are some important things you should know about Inlyta:
Uses
Inlyta is used to treat advanced kidney cancer that has spread to other parts of the body. It can be used as a first-line treatment for patients with advanced kidney cancer, as well as for patients who have already received other types of treatment. Inlyta is also sometimes used in combination with another medication called pembrolizumab to treat advanced kidney cancer.
Benefits
Inlyta has been shown to help shrink tumors and slow the progression of advanced kidney cancer. Clinical trials have demonstrated that Inlyta is more effective than placebo in treating advanced kidney cancer. It may also be more effective than some other types of TKI medications.
Side Effects
As with any medication, Inlyta can cause side effects. Some common side effects of Inlyta include:
– High blood pressure
– Diarrhea
– Fatigue
– Loss of appetite
– Nausea and vomiting
– Hand-foot syndrome (redness, swelling, and painful blisters on the palms of the hands and soles of the feet)
– Headaches
– Mouth sores
– Difficulty breathing
– Chest pain
– Swelling of the face, lips, tongue, or throat
In rare cases, Inlyta can cause serious side effects, such as liver damage, bleeding, and heart problems. If you experience any of these side effects, seek medical attention immediately.
Warnings
There are several important warnings associated with the use of Inlyta. Before taking this medication, you should let your doctor know if you have any of the following conditions:
– High blood pressure
– Liver problems
– Bleeding problems
– Heart problems
– Pregnancy or breastfeeding
Inlyta can interact with other medications, so make sure to tell your doctor about any other drugs you are taking, including over-the-counter medications and herbal supplements.
FAQs
Inlyta is taken orally, typically twice daily.
No, Inlyta is only approved for the treatment of advanced kidney cancer.
No, Inlyta can help shrink tumors and slow the progression of advanced kidney cancer, but it is not a cure.
There are no specific dietary restrictions associated with Inlyta.
The length of time you will need to take Inlyta will depend on your individual circumstances. Your doctor will be able to advise you on when it is appropriate to stop taking the medication.
